Opinion/decision on a Paediatric investigation plan (PIP): Enspryng, satralizumab, decision type: P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s), PIP number: P/0028/2023

Opinion/decision on a Paediatric investigation plan (PIP): Enspryng, satralizumab, decision type: P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s), PIP number: P/0028/2023